Grants

Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.

ArchivedFDA

Increasing the Quality and Efficiency of Clinical Trials (R18)

$7,500,000
Total funding
May 27, 2014
Posted
View opportunity →
ArchivedFDA

Development of an Integrated Mathematical Model for Comparative Characterization of Complex Molecules (U01)

$600,000
Total funding
May 19, 2014
Posted
View opportunity →
ArchivedFDA

Development of Process Simulation and Modeling Tools for Integrated Pharmaceutical Manufacturing Processes (U01)

$400,000
Total funding
May 19, 2014
Posted
View opportunity →
ArchivedFDA

Post-market surveillance evaluation of authorized generic drug products (U01)

$400,000
Total funding
Apr 29, 2014
Posted
View opportunity →
ArchivedFDA

Effect of Therapeutic Class on Generic Drug Substitutions (U01)

$400,000
Total funding
Apr 29, 2014
Posted
View opportunity →
ArchivedFDA

Pharmacokinetic/Pharmacodynamic (PK/PD) Studies of Methylphenidate Extended Release Products in Attention Deficit Hyperactivity Disorder (ADHD) Patients (U01)

$1,000,000
Total funding
Apr 29, 2014
Posted
View opportunity →
ArchivedFDA

Data Concepts and Terminology Standards for Clinical Research and Drug Development (U24)

$1,000,000
Total funding
Apr 29, 2014
Posted
View opportunity →
ArchivedFDA

Development of realistic in vitro studies to assess robustness of dose counters/indicators in metered dose inhalers (U01)

$500,000
Total funding
Apr 18, 2014
Posted
View opportunity →
ArchivedFDA

Evalution of Iron Species in Healthy Subjects treated with Generic and Reference Sodium Ferric Gluconate

$15,000,000
Total funding
Apr 18, 2014
Posted
View opportunity →
ArchivedFDA

Retrospective Analysis on the Impact of Generic Immunosuppressants on Acute Rejection and Long Term Graft Survivals (U01)

$2,000,000
Total funding
Apr 18, 2014
Posted
View opportunity →
ArchivedFDA

The Effect of Different Preparation Methods on the In Vitro and In Vivo Performance of Solid Dispersion Formulations (U01)

$1,500,000
Total funding
Apr 18, 2014
Posted
View opportunity →
ArchivedFDA

Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Cardiovascular Drugs (U01)

$3,000,000
Total funding
Apr 18, 2014
Posted
View opportunity →